- Home
- BDTX vs BCBP Comparison
BDTX vs BCBP Comparison
Compare BDTX & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | BCBP |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.9M | 139.1M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BDTX | BCBP |
|---|---|---|
| Price | $1.79 | $10.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | $9.67 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 1.6M | 164.8K |
| Earning Date | 05-08-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.10% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $85.26 |
| Revenue Next Year | N/A | $6.14 |
| P/E Ratio | ★ N/A | $38.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $7.31 |
| 52 Week High | $4.94 | $11.71 |
Technical Indicators
Market Signals| Indicator | BDTX | BCBP |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 46.51 |
| Support Level | $1.76 | $9.67 |
| Resistance Level | $2.26 | $10.60 |
| Average True Range (ATR) | 0.11 | 0.28 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 6.17 | 51.55 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.